Skip to main content

Traws Pharma Inc

For the period ended Jun 30, 2024. Filed Aug 15, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 15, 2024

TRAW$0.24+8.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

TABLE OF CONTENTS FOR QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED JUNE 30, 2024

​
​Page
PART I — FINANCIAL INFORMATION​
​​
Item 1. Financial Statements (Unaudited)3
Condensed Consolidated Balance Sheets3
Condensed Consolidated Statements of Operations4
Condensed Consolidated Statements of Comprehensive Loss5
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ (Deficit) Equity6
Condensed Consolidated Statements of Cash Flows8
Notes to Condensed Consolidated Financial Statements9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations22
Item 3. Quantitative and Qualitative Disclosures About Market Risk34
Item 4. Controls and Procedures34
​​
PART II — OTHER INFORMATION​
​​
Item 1. Legal Proceedings35
Item 1A. Risk Factors35
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds38
Item 3. Defaults Upon Senior Securities38
Item 4. Mine Safety Disclosures38
Item 5. Other Information38
Item 6. Exhibits39
SIGNATURES40
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.